Literature DB >> 7730158

Total structures and antimicrobial activity of bacitracin minor components.

Y Ikai1, H Oka, J Hayakawa, M Matsumoto, M Saito, K Harada, Y Mayumi, M Suzuki.   

Abstract

Total structures of 13 minor components of bacitracin (BC) were proposed, and their antimicrobial activities were investigated. The components of BC including bacitracins A (BC-A) and F (BC-F) were isolated by preparative HPLC and were hydrolyzed under acidic conditions. The resulting amino aids were derivatized with 1-fluoro-2,4-dinitrophenyl-5-L-alanineamide and were separated by HPLC to determine their absolute configurations. It was found that the N-terminal amino acids of BC-A and its related components were epimerized during the hydrolysis to yield their enantiomers. The formation of these artifactual amino acids suggests that our previously proposed structures of the BC minor components are incorrect; therefore, the structures were corrected based on these results. The structures of the BC minor components were the same as that of BCs-A and -F except that one to three of the L-isoleucines, including the N-terminal one, were replaced by L-valines. These structures were confirmed by tandem mass spectrometry under fast atom bombardment (FAB) conditions and Frit-FAB liquid chromatography/mass spectrometry. Based on the UV spectra of the BC components determined by photodiode array detection-HPLC analysis, a new systematic nonmenclature was proposed for the minor components. The isolated components were also used for the determination of their minimal inhibition concentrations and it was found that BC-A is 2 approximately 8 times more potent than the other minor components against strains of Micrococcus luteus and Staphylococcus aureus.

Entities:  

Mesh:

Substances:

Year:  1995        PMID: 7730158     DOI: 10.7164/antibiotics.48.233

Source DB:  PubMed          Journal:  J Antibiot (Tokyo)        ISSN: 0021-8820            Impact factor:   2.649


  5 in total

1.  Analytical characterization of peptide contaminants of L-tryptophan.

Authors:  E R Barnhart; V L Maggio; L R Alexander; M C Reilly; L T Gelbaum; W E Turner; T K Hine; L L Needham
Journal:  Arch Environ Contam Toxicol       Date:  1996-01       Impact factor: 2.804

2.  High-resolution crystal structure reveals molecular details of target recognition by bacitracin.

Authors:  Nicoleta J Economou; Simon Cocklin; Patrick J Loll
Journal:  Proc Natl Acad Sci U S A       Date:  2013-08-12       Impact factor: 11.205

3.  The stereoselectivity and hydrolysis efficiency of recombinant D-hydantoinase from Vigna angularis Against 5-benzylhydantoin derivatives with halogen and methyl substituents.

Authors:  Gniewomir Latacz; Katarzyna Kieć-Kononowicz
Journal:  Appl Biochem Biotechnol       Date:  2014-10-24       Impact factor: 2.926

4.  Analysis of bacitracin and its related substances by liquid chromatography tandem mass spectrometry.

Authors:  Suleiman Ahmed Suleiman; Fan Song; Mengxiang Su; Taijun Hang; Min Song
Journal:  J Pharm Anal       Date:  2016-06-21

5.  Synthesis, construction, and evaluation of self-assembled nano-bacitracin A as an efficient antibacterial agent in vitro and in vivo.

Authors:  Wei Hong; Xiang Gao; Peng Qiu; Jie Yang; Mingxi Qiao; Hong Shi; Dexian Zhang; Chunlian Tian; Shengli Niu; Mingchun Liu
Journal:  Int J Nanomedicine       Date:  2017-06-30
  5 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.